Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease

NCT01541579 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
278
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tigenix S.A.U.